The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-5-(2-(1H-indol-4-yl)-4-(3-methylmorpholino)quinazolin-6-yl)picolinonitrile ID: ALA5197038
PubChem CID: 168286376
Max Phase: Preclinical
Molecular Formula: C27H22N6O
Molecular Weight: 446.51
Associated Items:
Names and Identifiers Canonical SMILES: CC1COCCN1c1nc(-c2cccc3[nH]ccc23)nc2ccc(-c3ccc(C#N)nc3)cc12
Standard InChI: InChI=1S/C27H22N6O/c1-17-16-34-12-11-33(17)27-23-13-18(19-5-7-20(14-28)30-15-19)6-8-25(23)31-26(32-27)22-3-2-4-24-21(22)9-10-29-24/h2-10,13,15,17,29H,11-12,16H2,1H3
Standard InChI Key: NUTKSDJGTYDWBI-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 39 0 0 0 0 0 0 0 0999 V2000
3.2437 1.0273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9579 1.4404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9579 2.2643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2457 2.6715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5354 2.2589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5354 1.4391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8261 1.0293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1114 1.4425 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4035 1.0274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4035 0.2035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1135 -0.2052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8261 0.2054 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1135 -1.0245 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4028 -1.4319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4028 -2.2555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1134 -2.6715 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8242 -2.2557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8242 -1.4321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3061 -1.0212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3086 -0.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0196 0.2035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0196 1.0274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3086 1.4435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7286 -0.2071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4393 0.2003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1500 -0.2071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1500 -1.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4393 -1.4466 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7286 -1.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8607 -1.4382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5715 -1.8458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5715 0.8888 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2366 0.1347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4160 0.2203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
6 7 1 0
8 7 2 0
9 8 1 0
10 9 2 0
10 11 1 0
7 12 1 0
12 11 2 0
13 11 1 0
14 13 1 0
15 14 1 0
16 15 1 0
16 17 1 0
13 18 1 0
18 17 1 0
19 14 1 0
10 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
9 23 1 0
21 24 1 0
25 24 1 0
26 25 2 0
27 26 1 0
28 27 2 0
24 29 2 0
28 29 1 0
27 30 1 0
30 31 3 0
2 32 1 0
32 33 1 0
33 34 2 0
1 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 446.51Molecular Weight (Monoisotopic): 446.1855AlogP: 4.94#Rotatable Bonds: 3Polar Surface Area: 90.72Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.57CX LogP: 5.52CX LogD: 5.52Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.42Np Likeness Score: -1.03
References 1. Bin H, Chen P, Wu M, Wang F, Lin G, Pan S, Liu J, Mu B, Nan J, Huang Q, Li L, Yang S.. (2022) Discovery of a potent and highly selective inhibitor of ataxia telangiectasia mutated and Rad3-Related (ATR) kinase: Structural activity relationship and antitumor activity both in vitro and in vivo., 232 [PMID:35183872 ] [10.1016/j.ejmech.2022.114187 ]